A series of studies and reports highlight the potential benefits of medical cannabis in reducing opioid use among chronic pain patients. These findings suggest that cannabis may serve as an effective alternative for pain management, offering a safer option with fewer risks of addiction and overdose compared to opioids. MSA is actively exploring how cannabis can address broader health and wellness needs, using real-world data to conduct comprehensive studies. These efforts contribute to the growing body of evidence supporting the integration of medical cannabis into healthcare strategies to combat the opioid crisis and improve patient outcomes. If you’re interested in learning more or have questions, please reach out to Madeline Grant at mgrant@msa.com.
How Real-World Data Can Unlock Cannabis's Role in Opioid Reduction
Beard Bro Pharms | August 14, 2025
This article highlights the importance of real-world data drawn from electronic health records linked to point-of-sale information from licensed cannabis dispensaries to further research and education in the cannabis industry.
'All eyes are on Moab' for Utah's next rural medica cannabis pharmacy
Andrew Christiansen, The Times-Independent | April 16, 2025
This article highlights recent advancements in Utah's medical cannabis program and presents findings from MSA's study, which examines the link between medica cannabis use and reduced opioid consumption through real-world data in the state.
Utah Study Finds 84% of Patients Reduced Opioids After Cannabis Treatment
MMW Global News | December 3, 2024
This article presents findings from a recent Utah study indicating that cannabis can significantly reduce opioid prescriptions, with a 53% drop among chronic pain patients from 2021-2024.
PODCAST: One Mic Stand: DEEP DIVE with Management Science Associates
Audrey Russo and Jonathan Kersting, Pittsburgh Technology Council | December 15, 2023
Listen to the story of MSA’s growth and how it is looking to be a leader in the emerging cannabis industry.
Member Blog: Management Science Associates, Inc. Leads Research Initiatives Alongside Vireo Health
Brooke Gilbert, National Cannabis Industry Council | September 21, 2023
The article highlights Management Science Associates, Inc. (MSA) and Vireo Health’s collaborative research efforts within the cannabis industry. Together, they aim to address research gaps and enhance understanding through data-driven approaches.
Breaking New Ground: BDSA and MSA Forge Strategic Alliance to Deliver Next-Level Cannabis Industry Market Research and Analytics
BDSA | June 22, 2023
Data powerhouses work together to redefine understanding of cannabis consumers and markets
MSA offers insight into medical cannabis industry
Paul J. Gough | Mar 17, 2023
The article provides insights from Management Science Associates (MSA) into the medical cannabis industry. MSA, a data analytics firm, sheds light on various aspects of the industry, including market trends, consumer behavior, and regulatory developments. Through their analysis, MSA offers valuable information for businesses and stakeholders navigating the evolving landscape of medical cannabis.